Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma CDMO offers integrated end-to-end solutions for development & commercialization of intermediates & APIs for small molecules.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    veranova-m-2025-06-30

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Abatacept

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 9Orencia

    02 2Orencia

    03 8Orencia SC

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Orencia

    Abatacept

    arrow
    Discovery Europe
    Not Confirmed

    Brand Name : Orencia

    U.S.A
    arrow
    Discovery Europe
    Not Confirmed

    Bristol Myers Squibb

    Abatacept

    Main Therapeutic Indication : Immunology

    Currency : USD

    2020 Revenue in Millions : 3,157

    2019 Revenue in Millions : 2,977

    Growth (%) : 6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Orencia

    Abatacept

    arrow
    Discovery Europe
    Not Confirmed

    Brand Name : Orencia

    U.S.A
    arrow
    Discovery Europe
    Not Confirmed

    Bristol Myers Squibb

    Abatacept

    Main Therapeutic Indication : Immunology

    Currency : USD

    2021 Revenue in Millions : 3,306

    2020 Revenue in Millions : 3,157

    Growth (%) : 5

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Orencia SC

    Abatacept

    arrow
    Discovery Europe
    Not Confirmed

    Brand Name : Orencia SC

    Japan
    arrow
    Discovery Europe
    Not Confirmed

    Ono Pharma

    Abatacept

    Main Therapeutic Indication : Immunology

    Currency : USD

    2020 Revenue in Millions : 203

    2019 Revenue in Millions : 182

    Growth (%) : 11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Orencia SC

    Abatacept

    arrow
    Discovery Europe
    Not Confirmed

    Brand Name : Orencia SC

    Japan
    arrow
    Discovery Europe
    Not Confirmed

    Ono Pharma

    Abatacept

    Main Therapeutic Indication : Immunology

    Currency : USD

    2021 Revenue in Millions : 191

    2020 Revenue in Millions : 195

    Growth (%) : 6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Orencia

    Abatacept

    arrow
    Discovery Europe
    Not Confirmed

    Brand Name : Orencia

    U.S.A
    arrow
    Discovery Europe
    Not Confirmed

    Bristol Myers Squibb

    Abatacept

    Main Therapeutic Indication : Immunology

    Currency : USD

    2022 Revenue in Millions : 3,464

    2021 Revenue in Millions : 3,306

    Growth (%) : 5

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Orencia SC

    Abatacept

    arrow
    Discovery Europe
    Not Confirmed

    Brand Name : Orencia SC

    Japan
    arrow
    Discovery Europe
    Not Confirmed

    Ono Pharmaceuticals

    Abatacept

    Main Therapeutic Indication : Immunology

    Currency : USD

    2022 Revenue in Millions : 188

    2021 Revenue in Millions : 191

    Growth (%) : -2

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Orencia

    Abatacept

    arrow
    Discovery Europe
    Not Confirmed

    Brand Name : Orencia

    U.S.A
    arrow
    Discovery Europe
    Not Confirmed

    Bristol Myers Squibb

    Abatacept

    Main Therapeutic Indication : Immunology

    Currency : USD

    2023 Revenue in Millions : 3,601

    2022 Revenue in Millions : 3,464

    Growth (%) : 4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Orencia SC

    Abatacept

    arrow
    Discovery Europe
    Not Confirmed

    Brand Name : Orencia SC

    Japan
    arrow
    Discovery Europe
    Not Confirmed

    Ono Pharmaceuticals

    Abatacept

    Main Therapeutic Indication : Immunology

    Currency : USD

    2023 Revenue in Millions : 173

    2022 Revenue in Millions : 188

    Growth (%) : 5

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Orencia SC

    Abatacept

    arrow
    Discovery Europe
    Not Confirmed

    Brand Name : Orencia SC

    Japan
    arrow
    Discovery Europe
    Not Confirmed

    Ono Pharmaceuticals

    Abatacept

    Main Therapeutic Indication : Immunology

    Currency : USD

    2024 Revenue in Millions : 171

    2023 Revenue in Millions : 173

    Growth (%) : -1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Orencia

    Abatacept

    arrow
    Discovery Europe
    Not Confirmed

    Brand Name : Orencia

    U.S.A
    arrow
    Discovery Europe
    Not Confirmed

    Bristol Myers Squibb

    Abatacept

    Main Therapeutic Indication : Immunology

    Currency : USD

    2024 Revenue in Millions : 3,682

    2023 Revenue in Millions : 3,601

    Growth (%) : 2

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF